# Bioavailability and Safety Study Comparing Two Dose Levels of AMZ001 and One Dose Level of Diclofenac Sodium 1% Gel in Healthy Participants

> **NCT05968482** · PHASE1 · COMPLETED · sponsor: **Amzell** · enrollment: 74 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Diclofenac Sodium Gel

## Key facts

- **NCT ID:** NCT05968482
- **Lead sponsor:** Amzell
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-11
- **Primary completion:** 2023-12-27
- **Final completion:** 2024-12-02
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2025-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05968482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05968482, "Bioavailability and Safety Study Comparing Two Dose Levels of AMZ001 and One Dose Level of Diclofenac Sodium 1% Gel in Healthy Participants". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05968482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*